Maxim lowered the firm's price target on AmpliTech Group to $7 from $9 and keeps a Buy rating on the shares after its FY25 results and outlook. The company's "robust guidance" and two signed LOIs in excess of $100M support a major inflection point, though the firm is cutting its price target to reflect equity dilution, the analyst tells investors in a research note.
